RARα Luciferase Reporter HEK293 Cell Line

Catalog #
60503
$2,240 *
Size: 2 vials
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

RARα Luciferase Reporter HEK293 Cell Line are engineered HEK293 cells expressing a conditional firefly luciferase reporter under the control of retinoid acid response elements (RARE), and constitutively expressing full length human Retinoic Acid Receptor alpha (RARα, NM_0.00964). This cell line is functionally validated to respond to all-trans retinoic acid (ATRA) stimulation.

Figure 1: Activation of retinoid acid-dependent luciferase reporter in the RARα/RARα Luciferase Reporter HEK293 Cell Line.

Interested in screening and profiling inhibitors or activators of Retinoic Acid Receptor alpha without the need to purchase and license the cell line? Check out our Cell Signaling Pathway Screening.

This product has been cited 5 times.

Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.

Synonyms
RAR alpha, NCOR2, SMRT, RARA, Retinoic acid receptor alpha
Product Info
Storage and Usage
Citations5
Host Cell Line
HEK293, Human Embryonic Kidney, epithelial-like cells, adherent.
Supplied As
Each vial contains >1 x 106 cells in 1 ml of Cell Freezing Medium (BPS Bioscience #79796)
Materials Required But Not Supplied

Media Required for Cell Culture

Name Ordering Information
Thaw Medium 6 BPS Bioscience #60183
Growth Medium 6A BPS Bioscience #79542

Materials Required for Cellular Assay 

Name Ordering Information
ATRA Sigma #R2625
Assay Medium 6A BPS Bioscience #82211
96-well tissue culture treated white clear-bottom assay plate Corning #3610 
ONE-Step™ Luciferase Assay System BPS Bioscience #60690
Luminometer  
Genbank #
NM_000964
UniProt #
P10276
Mycoplasma Testing

The cell line has been screened to confirm the absence of Mycoplasma species.

Background

RAR (Retinoic Acid Receptor) belongs to a family of nuclear receptors and has three subtypes: RARa, RARb, and RARg. RAR heterodimerizes with RXR (Retinoid X Receptor) and acts as a transcription factor that regulates the growth and differentiation of both normal and malignant cells. When RAR binds to its ligands, all-trans retinoic acid (ATRA) or 9-cis retinoic acid, the RAR/ RXR heterodimer binds to the retinoic acid response elements in the promoter region of target genes. This recruits coactivator proteins, leading to transcription and expression of the downstream target genes. Retinoic acid (a derivative of Vitamin A) signaling plays critical roles in embryonic and immune system development. Mutations in RARα can lead to Acute Promyelocytic Leukemia (APL), characterized by the accumulation of progenitor cells from the blood lineage (promyelocytes), and other cancer types. Use of RA may prove beneficial in cancer therapy.

References
1. Petkovich, M, et al. Nature (1987) 330(6147): 444-450.
2. Allenby, G, et al. Proc. Natl. Acad. Sci. USA (1993) 90(1): 30-34.